Biocracked
Approach 3, the human outcome, in palette B, warm.

Low three-quarter rear angle, shot with a 50mm lens at shallow depth of field. A middle-aged person's forearm and hand grip a loaded barbell mid-deadlift, the tendons and the muscle of the forearm clearly defined, with chalk dust hanging in the air. Their face is out of frame. The setting is a plain home garage gym with a rubber floor and a rack softly blurred in the background. Low golden-hour sunlight comes through an open roll-up door and rakes across the skin and the knurled steel, casting long warm shadows. Amber, copper and honey tones dominate, with matte black plates for contrast. A tiny electric green silicone wristband or a small green pen injector resting on a nearby shelf adds a subtle accent. The mood is determined, quiet and hopeful.
Metabolism

Game da Tirzepatide? Ɗaga Nauyi Ya Ceton 1.1 kg na Tsokoki

Rex Meridian · · 5 min read

Tirzepatide na iya cire fiye da 22 kg a cikin makonni 40. Wani sabon gwaji na bazuwar ya nuna cewa, idan ba a yi horon ƙarfi ba, kusan 4.7 kg na asarar nauyin nan yana daga cikin lean soft tissue (ƙwayar jiki mara mai), kuma ƙarfi ya ragu. Ɗaga nauyi sau uku a mako ya canza wannan hoton.

Gwajin, da aka wallafa a Nature Medicine (online ahead of print, 2026), shine ɗaya daga cikin gwaje‑gwajen ɗan‑Adam mafi bayyane da suka tantance ko motsa jiki na ƙarfi na iya kare lean soft tissue yayin asarar nauyi da aka samu da maganin incretin.

Tsarin Gwaji: Mutane 120, Makonni 40, Magani Guda

Masana a Jami'ar Yammacin Australia da wasu cibiyoyi suka haɗa mutane 120 masu kiba. Kowa ya samu tirzepatide. Daga nan aka raba mahalarta zuwa rassan biyu:

  • Tirzepatide kai‑ka‑kai (T): ba tare da horon ƙarfi ba.
  • Tirzepatide + horon ƙarfi (T+REx): horon ƙarfi sau uku a mako.

Tsawon lokacin shine makonni 40. An tabbatar da amincin tirzepatide, kuma mafi yawan mahalarta sun ɗauki ƙarin 15 mg a mako, wato mafi girman kashi. Bin diddigin shirin horo ya kai 91 %.

Wannan gwaji ne na ɗan‑Adam na bazuwar, ba gwajin dabbobi ko ƙwayoyin ƙwaya ba. An rijista gwajin (ACTRN12623001236684).

Sakamakon Da Suka Bayyana

Nauyi da asarar kitse: iri ɗaya a duka rassan

  • Asarar nauyi: T = -22.61 kg vs T+REx = -22.28 kg (P = 0.694)
  • Asarar kitse: T = -17.19 kg vs T+REx = -17.98 kg (P = 0.700)

Bambancin kitse tsakanin rassan ya kasance -0.77 kg (95 % CI -2.14 zuwa 0.60 kg), don haka babu bambanci mai ma’ana.

Lean soft tissue (ƙwayar jiki mara mai): inda horon ƙarfi ya yi tasiri

  • Jimillar lean soft tissue: T = -4.67 kg vs T+REx = -3.57 kg (P < 0.001)
  • Bambanci tsakanin rassan: 1.09 kg (95 % CI 0.43 zuwa 1.75 kg)
  • Lean soft tissue a ƙafafu da hannaye: T = -3.55 kg vs T+REx = -2.92 kg (P < 0.001)

Masu horon ƙarfi ba su ƙara lean soft tissue ba, sai dai sun rasa ƙasa da 1 kg idan aka kwatanta da rukunin da ke amfani da magani kawai. Wannan kusan 25 % ne na raguwar lean soft tissue da ake samu a rukunin magani kadai. Takaitaccen labarin takarda ya bayyana wannan a matsayin "attenuation", kalmar da ta dace.

Ƙarfi: ya ragu a rukunin magani kadai, ya ƙaru da horon ƙarfi

Gwaji Tirzepatide kadai (T) Tirzepatide + REx
Bench press -4.09 kg +4.68 kg
Lat pulldown -4.42 kg +8.58 kg
Knee extension -4.42 kg +5.88 kg

Duk bambance‑bambancen da aka samu idan aka kwatanta da tirzepatide kadai sun kasance masu muhimmanci (P < 0.001). Ba tare da horo ba, ƙarfi a manyan ƙungiyoyi biyu ya ragu. Da horo kuwa, ya tashi a kowane gwaji.

Tsarin Horon: Abin Da Takardar Ta Bayyana

  • Yawan lokuta: sau uku a mako
  • Tsawon lokaci: makonni 40
  • Bin diddigi: 91 %
  • Rukunin tsokoki da aka auna: bench press (ƙoƙari na sama), lat pulldown (ja a sama) da knee extension (ƙoƙari na ƙasa)

Ba a bayyana adadin saiti, maimaita, ko nauyin da aka yi amfani da shi ba. Waɗannan cikakkun bayanai suna cikin takarda ta asali, don haka a duba su idan za a tsara shirin horo na musamman. Motsa jiki da aka gwada ya haɗa da push, pull, da ƙafa – wato horo mai cikakken jiki.

Abubuwan Da Za a Iya Aiwatarwa

  1. Shirya horon ƙarfi sau uku a mako. Wannan shine tsarin da ya haifar da sakamakon, kuma mahalarta sun bi shi kashi 91 % na lokuta.
  2. Rufe duk jiki. Ƙaruwar ƙarfi ta bayyana a push, pull da ƙafa, don haka shirin cikakken jiki ya fi dacewa.
  3. Sa ran ceton lean soft tissue, ba lallai ba ne gina sabuwar tsoka. Duka rukuni biyu sun rasa lean soft tissue, amma horon ƙarfi ya rage asarar kusan 1.1 kg.
  4. Kada ku yi tsammanin horon ƙarfi zai hana asarar kitse. Asarar nauyi da kitse sun kasance kusan iri ɗaya tsakanin rassan.
  5. Protein. Takardar ba ta ambaci yawan protein ba, don haka ba za a iya fitar da ƙayyadadden shawarwari ba. Ka’idodin abinci na wasanni da na sarcopenia suna ba da shawarar isasshen protein tare da horon ƙarfi. Yi magana da likita ko ƙwararren abinci don tantance adadi.
  6. Kwayar magani. Mafi yawan mahalarta sun kai 15 mg a mako, amma adadin magani likita ne ke saita, ba gwajin ba. Ɗaga nauyi ƙari ne, ba dalilin canza kwayar ba.

Waɗanda Ya Shafi

Sakamakon sun fi dacewa da manya masu kiba da ke shan tirzepatide (Mounjaro/Zepbound). Rasa lean soft tissue na da muhimmanci musamman ga manya, waɗanda ke da ƙarancin lean soft tissue kuma suna da ƙarin haɗarin rauni da faɗuwa. Takardar ba ta bayar da shekarun mahalarta ba, kuma ba ta yi nazarin ƙungiyoyi daban‑daban na manya ba, don haka ba a tabbatar da cewa sakamakon zai yi aiki ga su ba. Mutane masu cutar haɗin gwiwa, zuciya, ko wasu cututtuka su tattauna da likita kuma su nemi horo daga ƙwararren kafin su fara shirin horon ƙarfi.

Ƙayyadaddun Lura

  • "Lean soft tissue" ba tsoka tsantsa ba ce. Yana ƙunshe da ruwa da wasu ƙwayoyin jiki. Ƙaruwar ƙarfi na nuni da fa’idar aiki, amma ba a auna tsoka kai tsaye ba.
  • Wasu lean soft tissue har yanzu an rasa. Masu horon ƙarfi sun rasa 3.57 kg na lean soft tissue, don haka horon ƙarfi yana rage asara amma ba ya kawar da ita gaba ɗaya.
  • Tsawon lokaci. An bi mahalarta na makonni 40 kacal, kuma abin da zai faru bayan dakatar da magani ko horo ba a bayyana ba.
  • Alaka da kamfanoni. Wasu marubuta sun ambaci samun kuɗi daga kamfanonin magani, ciki har da Eli Lilly, wadda ke ƙera tirzepatide. Dukkan kuɗaɗen an tura su zuwa Jami'ar Yammacin Australia. Wani marubuci kuma ɗan hannun jari ne kuma mashawarci ga ProGenis Pharmaceuticals.

Gabaɗaya

Tirzepatide yana haifar da babban asarar nauyi da kitse shi kaɗai, amma kuma yana sa a rasa lean soft tissue da ƙarfi. Ƙara horon ƙarfi sau uku a mako na tsawon makonni 40 ya bar asarar kitse ba tare da canji ba, ya rage asarar lean soft tissue kusan 1.1 kg, kuma ya juya raguwar ƙarfi ya zama ƙaruwa. Ga masu amfani da maganin GLP‑1, wannan gwaji yana nuna cewa ya kamata a haɗa horon ƙarfi a cikin shirin magani. Wannan rubutu na bayanin ne kawai, ba shawara ta likita ba.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

RM

Written by

Rex Meridian

Rex Meridian writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: D, bold color field.

A single steel dumbbell sits in the center of a saturated tomato-red seamless backdrop. A thick, taut rope of frayed tan fibers wraps around its handle, and a few strands are visibly thinning and unraveling at one end while the rest stay dense and intact, standing for muscle being preserved while weight drops. Shot at a low three-quarter angle with a shallow depth of field, so the knurled grip texture is crisp and the background melts into smooth red. Hard, directional studio light from the upper left casts a sharp, short shadow on the glossy red surface. One thin electric green cable tie is cinched around the rope. The mood is punchy, tense and editorial, with no people and no text.
peptides

Menene Za a Hada da Tirzepinide Don Kula da Tsoka? Kure Sun Ba da Shaida

BY NOVA CHEN ·

Tirzepinide na rage kiba cikin sauri, amma me ke faruwa da tsokar jiki? Wani sabon bincike a *The Journal of Physiology* ya gwada maganin kai tsaye tare da cin abinci a lokutan iyaka (TRF) da horon ƙarfi. Haɗin gwiwar ya haifar da ragin nauyi da kitse mai sauri, horon ƙarfi ya kiyaye tsoka da ƙarfi, yayin da TRF da tirzepinide suka inganta sarrafa sukari. Sai dai fa'idar hanta ba ta bambanta ba a dukkan hanyoyin. Wannan bincike na dabbobi ne kawai a kan ƙure masu kiba, don haka a ɗauke shi a matsayin alamar bege, ba a matsayin tsarin da za a bi a mutane ba.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Shin Ozempic da Mounjaro Suna Haifar da Tunani na Kashe Kai? Abin da Bincike 20 Ya Gano

BY DR. SYNAPSE ·

Shin magungunan Ozempic da Mounjaro na ƙara haɗarin damuwa, fargaba ko tunani na kashe kai? Bincike mai tsari da aka wallafa a *Rambam Maimonides Medical Journal* ya nuna cewa hujjojin da suka fi ƙarfi ba su tabbatar da wannan haɗari ba. Gwaje‑gwajen da aka yi da tsarin bazuwar ba su nuna ƙaruwa a haɗarin tunani na kashe kai, damuwa ko fargaba ga masu amfani da semaglutide ko tirzepatide ba. Sai dai akwai buƙatar ci gaba da sa ido ga waɗanda ke da tarihin cutar kwakwalwa.

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutide Ba Ya Rage Kwayoyin Tsoka na Dan Adam. To Me Ya Sa Akwai Rashin Tsoka?

BY DR. SYNAPSE ·

Shin semaglutide yana lalata tsokar ka? Sabon binciken *GeroScience* ya gwada maganin kai tsaye a kan ƙwayoyin tsoka na manya masu kiba, inda ba a ga wata alamar lalacewa ba. Babu alamar atrophy, babu canjin secretome, har ma GIP ya ƙara kauri ga myotubes bayan kwanaki takwas. Semaglutide ya rage ɗan ƙanƙanta samar da ATP ta glycolysis, amma GLP‑1 receptors ba su yawaita ba a ƙwayoyin. Sakamakon na nuni da cewa asarar tsoka da ake gani a asibiti na da alaƙa da ƙarancin kalori da rage ɗagawa, ba da kai tsaye ga maganin ba.

Approach: Macro science. Palette: B, warm.

Extreme macro photograph of a clear glass vial of blood plasma held in a gloved hand, shot at a slight low angle so the camera looks up through the tube. The plasma is cloudy and creamy at the top, where large fat-rich particles gather, and it clears to translucent golden amber toward the bottom, showing the drop in triglyceride particles. Tiny suspended droplets catch the light as bright specks. Warm honey-colored backlight from a low window-like source glows through the liquid and casts copper highlights across the glass. The background is a soft blur of warm brown and amber, with a faint electric green reflection on the rim of the vial cap. The mood is calm, precise and cautious, with a shallow depth of field and a real clinical texture on the glass. No text or labels.
metabolism

Retatrutide Ya Rage Manyan Kwayoyin Triglyceride Har Zuwa Kashi 84% — Amma Ka Karanta Wannan Da Farko

BY DR. SYNAPSE ·

Retatrutide an fi sani da taimakon rage kiba, amma wani sabon binciken bayan‑bayan na gwaje‑gwajen mataki na biyu ya duba yadda yake tasiri a jinin mutane. Kwayoyin lipoprotein masu ɗauke da triglyceride manya sun ragu da har zuwa kashi 84.4 % a masu cutar sukari na nau’i 2, kuma ApoB ya ragu da kusan kashi 21–24 %. A cikin ƙungiyar da ba su da cutar sukari, hsCRP ya sauka da 54.8 % kuma IL‑6 da 29.6 %, amma waɗannan canje‑canjen ba su da ma’ana a cikin ƙungiyar masu cutar sukari. Takardar ba ta ba da sakamakon Lp(a) ko rarraba bisa ga dose ba. Maganin har yanzu ba a amince da shi ba; ba kari ba ne, kuma ƙididdigar da aka nuna alamomi ne kawai, ba tabbacin rage haɗarin cutar zuciya ba.

This page is available in